The SEICHE Center for Health and Justice, an academic collaboration between the Yale School of Medicine and Yale Law School, has chosen UF Radiation Oncology Assistant Professor Oluwadamilola T. Oladeru (Lola), MD, MA, MBA (right) as an affiliate faculty member, effective October 4. The mission of the SEICHE Center is…
An article featured September 28, 2022 in U.S. News & World Report focuses on the research of UF Radiation Oncology assistant professor Oluwadamilola T. Oladeru (Lola), MD, MA, MBA. Dr. Oladeru’s study, “Incarceration status and cancer mortality: A population-based study,” initially published September 16, 2022 in PLOS…
The UF College of Medicine has recognized Radiation Oncology Assistant Professor Oluwadamilola T. Oladeru, M.D., M.A., M.B.A., as a trailblazer during Women in Medicine Month. “Being an immigrant and a woman in medicine has taught me the power of resilience — you really have to build a resilient mindset,” said…
UF Radiation Oncology Assistant Professor Oluwadamilola T. Oladeru (Lola), MD, MA, MBA has been awarded a $240,000, two-year grant from the Bristol Myers Squibb Foundation’s prestigious Diversity in Clinical Trials Career Development Program (BMSF DCTCDP). The goal of the program is to build partnerships between clinical investigators and communities in…
Oluwadamilola Oladeru (Lola), MD, MA, MBA, Assistant Professor, Department of Radiation Oncology, and Director of the Breast Radiation Oncology service at Gainesville, has been awarded a grant by the NRG Oncology Early Career New Investigator and Health Disparities Committees for the Health Equity New Investigator Mentor Program for Underrepresented Minority…
NATIONALLY RANKED
Nationally ranked in 6 adult specialties and 6 pediatric specialties and rated high performing in 4 adult specialties and 5 procedures and conditions.
DEFINING OPTIMAL TREATMENTS
The seminar has three concurrent programs for radiation therapy, oncology nursing, and radiation oncology.
EXPLORE THE
Our Mission is to prevent, detect, treat and ultimately cure cancer while addressing the unique challenges of the cancer burden faced by the people we serve.
